EUVIMEDOpdag EUVIMED
Crossref

Synthesis and Bioactivity of Novel 1,2,4‐Oxadiazole–Sulfonamide Hybrids as Potent Antibacterial Agents Against Klebsiella pneumoniae

Zohaib Saifi, Asghar Ali, Haider Thaer Abdulhameed Almuqdadi, Amir Azam, Mohammad Abid iD, Imran Ali

Chemistry & Biodiversity · 2026-03 · 23 (3)

DOI: 10.1002/cbdv.202503582 ↗

At a glance

Journal article in Chemistry & Biodiversity, published online on 2026-03-12. Written by Zohaib Saifi and 5 co-authors. Institution: Department of Chemistry, Jamia Millia Islamia, New Delhi, India. Major MEDLINE topics: Sulfonamides, Anti-Bacterial Agents. 44 references. Funded by: Core Research Grant.

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

To combat resistant bacterial strains, a series of compounds (8a–8n) were synthesized in moderate to excellent yields (32.8–94.0%). These analogs were subjected to preliminary screening against various bacterial strains, including Enterococcus faecalis , Escherichia coli, Bacillus subtills, Staphylococcus aureus, Pseudomonas aeruginosa , and Klebsiella pneumoniae , to evaluate their effectiveness as antibacterial agents. Compounds 8f and 8i were the most effective derivatives, displaying their best antibacterial activity against K. pneumoniae with MIC values of 16 and 32 µg/mL, respectively. Additionally, compound 8f demonstrated a beneficial synergistic effect with ampicillin. The compound 8f was found to show good interactions with dihydropteroate synthase via hydrogen bonding, π‐cation interaction and π‐π stacking interactions. The binding free energy (BFE) value was calculated to be −63.91 Kcal/mol. The molecular dynamics simulation showed low RMSD values (0.6 to 2.2 Å) of DHPS‐ 8f complex and apoprotein, suggesting a stronger binding affinity. Importantly, it exhibited no toxicity toward human red blood cells (hRBC). Furthermore, the absorption, distribution, metabolism, and excretion (ADME) profile of 8f indicated its favorable drug‐like characteristics.

Subjects

MeSH terms (MEDLINE)

SulfonamidesAnti-Bacterial AgentsKlebsiella pneumoniaeMolecular Dynamics SimulationStructure-Activity RelationshipOxadiazoles

Author keywords

1,2,4‐oxadiazole‐sulfonamideDHPSMDRantibacterial agentshybridsimulation

Substances

1,2,4-oxadiazoleSulfonamidesAnti-Bacterial AgentsOxadiazoles

Authors and institutions

  • Department of Chemistry, Jamia Millia Islamia, New Delhi, India.
  • Department of Biosciences, Jamia Millia Islamia, New Delhi, India.
  • Department of Biochemistry, School of Chemical and Life Sciences, Jamia Hamdard, New Delhi, India.
  • Department of Chemistry, College of Science, Al-Nahrain University, Baghdad, Iraq.

ORCID profiles: Mohammad Abid

Funding

  • Core Research Grant

Cite

APA

Saifi, Z., Ali, A., Almuqdadi, H. T. A., Azam, A., Abid, M., & Ali, I. (2026). Synthesis and Bioactivity of Novel 1,2,4‐Oxadiazole–Sulfonamide Hybrids as Potent Antibacterial Agents Against Klebsiella pneumoniae. Chemistry & Biodiversity, 23(3). https://doi.org/10.1002/cbdv.202503582

Vancouver

Saifi Z, Ali A, Almuqdadi HTA, Azam A, Abid M, Ali I. Synthesis and Bioactivity of Novel 1,2,4‐Oxadiazole–Sulfonamide Hybrids as Potent Antibacterial Agents Against Klebsiella pneumoniae. Chemistry & Biodiversity. 2026;23(3). doi:10.1002/cbdv.202503582

BibTeX
@article{Saifi2026,
  author = {Saifi, Zohaib and Ali, Asghar and Almuqdadi, Haider Thaer Abdulhameed and Azam, Amir and Abid, Mohammad and Ali, Imran},
  title = {Synthesis and Bioactivity of Novel 1,2,4‐Oxadiazole–Sulfonamide Hybrids as Potent Antibacterial Agents Against Klebsiella pneumoniae},
  journal = {Chemistry & Biodiversity},
  year = {2026},
  volume = {23},
  number = {3},
  doi = {10.1002/cbdv.202503582}
}
Start for free →